BUSINESS PEOPLE; Big Acquisition Is Part Of Rorer Leader's Plan

Mr. [Robert E. Cawthorn], who was born in Britain, first joined Rorer in 1982 as president of Rorer International. Rorer began as a small family pharmaceutical firm in Fort Washington, Pa., and its major product was Maalox, an antacid. Maalox is still a major Rorer product and the company is still b...

Full description

Saved in:
Bibliographic Details
Published inThe New York times
Main Author Fisher, Daniel F. Cuff and Lawrence M.
Format Newspaper Article
LanguageEnglish
Published New York, N.Y New York Times Company 20.04.1987
EditionLate Edition (East Coast)
Subjects
BIOGRAPHICAL INFORMATION
CAWTHON, ROBERT E
Cawthorn, Robert E
CUFF, DANIEL F
FISHER, LAWRENCE M
MERGERS, ACQUISITIONS AND DIVESTITURES
Online AccessGet full text

Cover

More Information
Summary:Mr. [Robert E. Cawthorn], who was born in Britain, first joined Rorer in 1982 as president of Rorer International. Rorer began as a small family pharmaceutical firm in Fort Washington, Pa., and its major product was Maalox, an antacid. Maalox is still a major Rorer product and the company is still based in Fort Washington. But most everything else has changed. He has already doubled the company's size by acquiring Revlon's precription drug unit for $690 million, and he has restructured operations, trimmed the number of employees and recruited new executives. One member of the [Rorer] family, William H. Rorer 3d, resigned as a senior vice president in March to become president of Delaware Valley College.
ISSN:0362-4331